Cargando…
Anticancer agents against malaria: time to revisit?
The emergence of artemisinin resistance could adversely impact the current strategy for malaria treatment; thus, new drugs are urgently needed. A possible approach to developing new antimalarials is to find new uses for old drugs. Some anticancer agents such as methotrexate and trimetrexate are acti...
Autores principales: | Nzila, Alexis, Okombo, John, Becker, Ruy Perez, Chilengi, Roma, Lang, Trudie, Niehues, Tim |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2927876/ https://www.ncbi.nlm.nih.gov/pubmed/20056487 http://dx.doi.org/10.1016/j.pt.2009.12.002 |
Ejemplares similares
-
A phase I trial to evaluate the safety and pharmacokinetics of low-dose methotrexate as an anti-malarial drug in Kenyan adult healthy volunteers
por: Chilengi, Roma, et al.
Publicado: (2011) -
Is vaccine the magic bullet for malaria elimination? A reality check
por: Chilengi, Roma, et al.
Publicado: (2010) -
Experience of using an open source clinical trials data management software system in Kenya
por: Ngari, Moses M, et al.
Publicado: (2014) -
Injectable anti-malarials revisited: discovery and development of new agents to protect against malaria
por: Macintyre, Fiona, et al.
Publicado: (2018) -
Effect of folate derivatives on the activity of antifolate drugs used against malaria and cancer
por: Nduati, Eunice, et al.
Publicado: (2008)